<unk> , also known as levo-α-acetylmethadol (LAAM) is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites. It was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, the product ORLAAM was removed from the European market due to reports of severe cardiac-related adverse events. In 2003, Roxane Laboratories, Inc. discontinued ORLAAM in the US.
Levomethadyl Acetate
Vamidothion
Sodium fluoride
Morniflumate
Povidone-iodine
Calcium iodide
Tibezonium iodide
Potassium iodide